Sector portfolio · Private equity · Hong Kong SAR China
Ally Bridge Group's Biotech portfolio
Ally Bridge Group has backed 13 Biotech startups in rounds we track, $2.1B between them, shown by the stage each has reached. The best-funded is Advancell.
Funding by segment
- Series C and later$1.8B11
- Series B$287M2
Where they are based
- United States8$1.0B
- China3$508M
- Australia1$438M
- Hong Kong SAR China1$150M
United States
China
Australia
Hong Kong SAR ChinaFounded
2 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M2
- $50M to $250M9
- $250M to $1B2
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
11 of 13 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States8
- China3
- Australia1
- Hong Kong SAR China1
Startups by country, 4 countries in all.
Segment by segment
Series C and later
11 startups · $1.8B raised
AdvanCellAdvanCell is radiopharmaceutical firm that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.Australia$438M
SetPoint MedicalSetPoint Medical is a commercial-stage medical technology company founded in 2007, focused on developing bioelectronic therapies fUnited States$256M- II-MabChina$220M
Imperative CareImperative Care is a medical technology company based in Campbell, California, focused on developing innovations for patients withUnited States$196M
Elligo Health ResearchElligo Health Research brings clinical research to physician practices and accelerate the development of medical device and therapies.United States$160M- IInnoventHong Kong SAR China$150M
- 3B3-V BiosciencesUnited States$146M
GenFleet TherapeuticsGenFleet Therapeutics is a biotechnology developer and researcher of molecular pharmaceuticals targeting cancer treatments.China$96M
Series B
2 startups · $287M raised
Hua MedicineHua Medicine is a clinical-stage, innovative drug development company in China.China$192M
Conventus OrthopaedicsConventus Orthopaedics is a provider of a range of orthopedic and sports medicine services.United States$94M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Ally Bridge Group as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Ally Bridge Group?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.